| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2026 ( Subtotal = $69,088,094 ) (Continued on the next page) |
| | 2026 | 2026 | MAYO CLINIC | 200 1ST ST SW | ROCHESTER | MN | 55905-0001 | OLMSTED | USA | R01GM144351 | Methods for microbiome compositional data | 001 | 5 | NIH | 3/10/2026 | $32,788 |
| | 2026 | 2026 | MAYO CLINIC | 200 1ST ST SW | ROCHESTER | MN | 55905-0001 | OLMSTED | USA | R01GM144351 | Methods for microbiome compositional data | 000 | 5 | NIH | 1/15/2026 | $295,088 |
| | 2026 | 2026 | MAYO CLINIC | 200 1ST ST SW | ROCHESTER | MN | 55905-0001 | OLMSTED | USA | R01EB038746 | Overcoming Challenging Clinical Scenarios in Non-invasive Coronary Artery Imaging using Next Generation Photon Counting Detector CT and Artificial Intelligence | 001 | 1 | NIH | 4/6/2026 | $0 |
| | 2026 | 2026 | MAYO CLINIC | 200 1ST ST SW | ROCHESTER | MN | 55905-0001 | OLMSTED | USA | R01EB038746 | Overcoming Challenging Clinical Scenarios in Non-invasive Coronary Artery Imaging using Next Generation Photon Counting Detector CT and Artificial Intelligence | 000 | 1 | NIH | 3/26/2026 | $625,527 |
| | 2026 | 2026 | MAYO CLINIC | 200 1ST ST SW | ROCHESTER | MN | 55905-0001 | OLMSTED | USA | R01EB036987 | AI-assisted quantitative photon-counting-detector CT imaging for cytogenetic risk prediction and treatment response in multiple myeloma | 000 | 2 | NIH | 1/30/2026 | $474,398 |
| | 2026 | 2026 | MAYO CLINIC | 200 1ST ST SW | ROCHESTER | MN | 55905-0001 | OLMSTED | USA | R01DK134366 | Immune Outcomes to Neonatal Antigen Delivery in the Intestine | 000 | 4 | NIH | 4/9/2026 | $388,504 |
| | 2026 | 2026 | MAYO CLINIC | 200 1ST ST SW | ROCHESTER | MN | 55905-0001 | OLMSTED | USA | R01DK134448 | NAFLD Diagnosis and Outcomes | 000 | 3 | NIH | 1/14/2026 | $530,351 |
| | 2026 | 2026 | MAYO CLINIC | 200 1ST ST SW | ROCHESTER | MN | 55905-0001 | OLMSTED | USA | R01DK132718 | Noninvasive assessment of portal hypertension and hepatic interstitial pressure with advanced magnetic resonance elastography | 000 | 4 | NIH | 1/27/2026 | $345,420 |
| | 2026 | 2026 | MAYO CLINIC | 200 1ST ST SW | ROCHESTER | MN | 55905-0001 | OLMSTED | USA | R01DK133401 | Heme-mediated Mitochondrial Injury, Senescence, Acute Kidney Injury and Chronic Kidney Disease | 000 | 4 | NIH | 1/12/2026 | $599,173 |
| | 2026 | 2026 | MAYO CLINIC | 200 1ST ST SW | ROCHESTER | MN | 55905-0001 | OLMSTED | USA | R01EB035553 | Improving the dose efficiency of photon counting CT | 000 | 3 | NIH | 4/13/2026 | $359,315 |
| | 2026 | 2026 | MAYO CLINIC | 200 1ST ST SW | ROCHESTER | MN | 55905-0001 | OLMSTED | USA | R01EB033008 | Development of an ultrasound detectable, migration-resistant biopsy marker for improving care in patients with breast cancer | 000 | 4 | NIH | 1/7/2026 | $487,266 |
| | 2026 | 2026 | MAYO CLINIC | 200 1ST ST SW | ROCHESTER | MN | 55905-0001 | OLMSTED | USA | R01DK136511 | Pathobiology of liver fibrosis | 000 | 4 | NIH | 4/1/2026 | $355,080 |
| | 2026 | 2026 | MAYO CLINIC | 200 1ST ST SW | ROCHESTER | MN | 55905-0001 | OLMSTED | USA | R01DK136731 | Quantitative characterization of the liver-pancreas axis in diabetes via multiparametric magnetic resonance elastography | 000 | 4 | NIH | 4/27/2026 | $399,749 |
| | 2026 | 2026 | MAYO CLINIC | 200 1ST ST SW | ROCHESTER | MN | 55905-0001 | OLMSTED | USA | R01DK138998 | Characterization of microvasculature in kidney transplant by super-resolution ultrasound imaging | 000 | 3 | NIH | 2/26/2026 | $568,357 |
| | 2026 | 2026 | MAYO CLINIC | 200 1ST ST SW | ROCHESTER | MN | 55905-0001 | OLMSTED | USA | R01DK136208 | Inhibition of autoimmune diabetes by ST8Sia6 | 000 | 3 | NIH | 2/28/2026 | $454,682 |
| | 2026 | 2026 | MAYO CLINIC | 200 1ST ST SW | ROCHESTER | MN | 55905-0001 | OLMSTED | USA | R01DK137231 | Engineering microcapsules for scalable differentiation of human pluripotent stem cells into hepatocytes | 000 | 3 | NIH | 2/13/2026 | $555,713 |
| | 2026 | 2026 | MAYO CLINIC | 200 1ST ST SW | ROCHESTER | MN | 55905-0001 | OLMSTED | USA | R01DK139607 | Investigate the trafficking and function of polycystins in primary cilia and their implications for polycystic kidney disease | 000 | 3 | NIH | 1/9/2026 | $541,708 |
| | 2026 | 2026 | MAYO CLINIC | 200 1ST ST SW | ROCHESTER | MN | 55905-0001 | OLMSTED | USA | R01DK145578 | Reversing abnormal metabolism in mild autonomous cortisol secretion (MACS) | 000 | 1 | NIH | 2/17/2026 | $741,387 |
| | 2026 | 2026 | MAYO CLINIC | 200 1ST ST SW | ROCHESTER | MN | 55905-0001 | OLMSTED | USA | R01DK142826 | Molecular mechanisms of sexually dimorphic traits of interstitial cells of Cajal and their role in gastrointestinal neuromuscular disorders | 000 | 1 | NIH | 3/26/2026 | $634,994 |
| | 2026 | 2026 | MAYO CLINIC | 200 1ST ST SW | ROCHESTER | MN | 55905-0001 | OLMSTED | USA | R01EB017095 | Diagnostic performance assessment and dose optimization using patient CT images: Application to deep-learning CT reconstruction and denoising technologies | 000 | 12 | NIH | 1/7/2026 | $421,277 |
| | 2026 | 2026 | MAYO CLINIC | 200 1ST ST SW | ROCHESTER | MN | 55905-0001 | OLMSTED | USA | R01DK142606 | A Randomized, placebo-controlled trial of the effects of Long-Acting GLP-1 or Dual Incretin (GLP-1 and GIP) Modulation on Gastrointestinal Functions and Relationship to Weight Loss | 000 | 2 | NIH | 4/9/2026 | $322,800 |
| | 2026 | 2026 | MAYO CLINIC | 200 1ST ST SW | ROCHESTER | MN | 55905-0001 | OLMSTED | USA | R01DK145433 | Acute Kidney Injury in Care Transitions: The ACT Pragmatic Trial | 000 | 1 | NIH | 3/3/2026 | $796,370 |
| | 2026 | 2026 | MAYO CLINIC | 200 1ST ST SW | ROCHESTER | MN | 55905-0001 | OLMSTED | USA | R01DK142296 | Autophagic Processes and Hepatocellular Steatosis | 000 | 1 | NIH | 2/18/2026 | $495,130 |
| | 2026 | 2026 | MAYO CLINIC | 200 1ST ST SW | ROCHESTER | MN | 55905-0001 | OLMSTED | USA | R01DK129205 | Renal Microvessel Imaging for Characterization of Chronic Kidney Disease | 000 | 4 | NIH | 12/18/2025 | $530,101 |
| | 2026 | 2026 | MAYO CLINIC | 200 1ST ST SW | ROCHESTER | MN | 55905-0001 | OLMSTED | USA | R01DK130854 | Role of SLCO3A1 in macrophage metabolite sensing and IBD | 000 | 4 | NIH | 1/14/2026 | $349,800 |
| | 2026 | 2026 | MAYO CLINIC | 200 1ST ST SW | ROCHESTER | MN | 55905-0001 | OLMSTED | USA | R37CA276005 | Aak1 to increase infiltration of adoptively transferred cells into solid tumors | 000 | 4 | NIH | 1/27/2026 | $411,873 |
| | 2026 | 2026 | MAYO CLINIC | 200 1ST ST SW | ROCHESTER | MN | 55905-0001 | OLMSTED | USA | R37NS089757 | Longitudinal multi-modal imaging in progressive supranuclear palsy syndromes | 000 | 11 | NIH | 2/16/2026 | $3,746,535 |
| | 2026 | 2026 | MAYO CLINIC | 200 1ST ST SW | ROCHESTER | MN | 55905-0001 | OLMSTED | USA | R37CA276005 | Aak1 to increase infiltration of adoptively transferred cells into solid tumors | 001 | 4 | NIH | 4/16/2026 | $45,762 |
| | 2026 | 2026 | MAYO CLINIC | 200 1ST ST SW | ROCHESTER | MN | 55905-0001 | OLMSTED | USA | R35GM143949 | Fundamental and applied studies of nucleic acids | 000 | 5 | NIH | 3/23/2026 | $397,500 |
| | 2026 | 2026 | MAYO CLINIC | 200 1ST ST SW | ROCHESTER | MN | 55905-0001 | OLMSTED | USA | R33NS122096 | Intracranial D-2-Hydroxyglutarate as a Monitoring Biomarker for IDH-mutant Glioma. | 001 | 5 | NIH | 4/22/2026 | $39,779 |
| | 2026 | 2026 | MAYO CLINIC | 200 1ST ST SW | ROCHESTER | MN | 55905-0001 | OLMSTED | USA | R33NS122096 | Intracranial D-2-Hydroxyglutarate as a Monitoring Biomarker for IDH-mutant Glioma. | 000 | 5 | NIH | 3/5/2026 | $358,007 |
| | 2026 | 2026 | MAYO CLINIC | 200 1ST ST SW | ROCHESTER | MN | 55905-0001 | OLMSTED | USA | R25DK101405 | Mayo Clinic Nephrology & Urology Summer Undergraduate Research Fellowship (nuSURF) | 000 | 13 | NIH | 3/24/2026 | $132,204 |
| | 2026 | 2026 | MAYO CLINIC | 200 1ST ST SW | ROCHESTER | MN | 55905-0001 | OLMSTED | USA | R21AG097887 | Real world impact of glucagon-like peptide receptor agonist (GLP-1 RA) use on older adults | 000 | 1 | NIH | 3/13/2026 | $443,850 |
| | 2026 | 2026 | MAYO CLINIC | 200 1ST ST SW | ROCHESTER | MN | 55905-0001 | OLMSTED | USA | R21CA288898 | Evaluating Maintenance In Light chain Amyloidosis (EMILIA) | 001 | 2 | NIH | 4/21/2026 | $18,869 |
| | 2026 | 2026 | MAYO CLINIC | 200 1ST ST SW | ROCHESTER | MN | 55905-0001 | OLMSTED | USA | R21CA288898 | Evaluating Maintenance In Light chain Amyloidosis (EMILIA) | 000 | 2 | NIH | 12/17/2025 | $169,826 |
| | 2026 | 2026 | MAYO CLINIC | 200 1ST ST SW | ROCHESTER | MN | 55905-0001 | OLMSTED | USA | R21CA277138 | Novel 3D DWI for Detection and Characterization of Prostate Cancer in Men with Pelvic Metal Implants | 001 | 3 | NIH | 4/16/2026 | $22,637 |
| | 2026 | 2026 | MAYO CLINIC | 200 1ST ST SW | ROCHESTER | MN | 55905-0001 | OLMSTED | USA | R21CA277138 | Novel 3D DWI for Detection and Characterization of Prostate Cancer in Men with Pelvic Metal Implants | 000 | 3 | NIH | 12/11/2025 | $203,727 |
| | 2026 | 2026 | MAYO CLINIC | 200 1ST ST SW | ROCHESTER | MN | 55905-0001 | OLMSTED | USA | R21CA286349 | Characterization and treatment of a novel model of radiation optic neuropathy using the tree shrew | 000 | 3 | NIH | 3/26/2026 | $121,171 |
| | 2026 | 2026 | MAYO CLINIC | 200 1ST ST SW | ROCHESTER | MN | 55905-0001 | OLMSTED | USA | R21AI188334 | Discovery of efflux pump inhibitors using a high-throughout bacterial assay | 001 | 2 | NIH | 12/29/2025 | $201,750 |
| | 2026 | 2026 | MAYO CLINIC | 200 1ST ST SW | ROCHESTER | MN | 55905-0001 | OLMSTED | USA | R21AI190265 | C. albicans Induced Immune Skewing in Early Life | 000 | 1 | NIH | 2/3/2026 | $443,850 |
| | 2026 | 2026 | MAYO CLINIC | 200 1ST ST SW | ROCHESTER | MN | 55905-0001 | OLMSTED | USA | R01NS129549 | Development of an innovative in vivo voltammetric technique for measurements of tonic serotonin concentrations in the mammalian brain. | 000 | 4 | NIH | 3/23/2026 | $588,493 |
| | 2026 | 2026 | MAYO CLINIC | 200 1ST ST SW | ROCHESTER | MN | 55905-0001 | OLMSTED | USA | R01NS076491 | Computational and Biological Approach to Flow Diversion | 001 | 15 | NIH | 3/25/2026 | $45,034 |
| | 2026 | 2026 | MAYO CLINIC | 200 1ST ST SW | ROCHESTER | MN | 55905-0001 | OLMSTED | USA | R01NS076491 | Computational and Biological Approach to Flow Diversion | 000 | 15 | NIH | 12/10/2025 | $405,317 |
| | 2026 | 2026 | MAYO CLINIC | 200 1ST ST SW | ROCHESTER | MN | 55905-0001 | OLMSTED | USA | R01NS126227 | Seronegative Autoimmune Encephalopathies: Biomarker Discovery, Validation & Deep Phenotyping | 000 | 5 | NIH | 2/23/2026 | $397,500 |
| | 2026 | 2026 | MAYO CLINIC | 200 1ST ST SW | ROCHESTER | MN | 55905-0001 | OLMSTED | USA | R01NS103212 | CD8 T cell mediated disruption of Blood Brain Barrier Tight Junctions | 001 | 10 | NIH | 2/23/2026 | $593,164 |
| | 2026 | 2026 | MAYO CLINIC | 200 1ST ST SW | ROCHESTER | MN | 55905-0001 | OLMSTED | USA | R01NS113828 | Utilizing epidemiology, imaging and fluid biomarkers in MOG antibody-associated disease to inform prognosis, pathogenesis and therapeutics | 000 | 6 | NIH | 2/24/2026 | $638,605 |
| | 2026 | 2026 | MAYO CLINIC | 200 1ST ST SW | ROCHESTER | MN | 55905-0001 | OLMSTED | USA | R01MH131623 | Uncovering the origin of hypermutability in adult brains | 000 | 3 | NIH | 12/10/2025 | $844,959 |
| | 2026 | 2026 | MAYO CLINIC | 200 1ST ST SW | ROCHESTER | MN | 55905-0001 | OLMSTED | USA | R01HL171097 | Unraveling the cell divergent roles of Glucocorticoid-Induced TNF-R Related Protein (GITR): A new opportunity to treat atherosclerosis using targeted immunotherapy | 000 | 2 | NIH | 2/16/2026 | $690,965 |
| | 2026 | 2026 | MAYO CLINIC | 200 1ST ST SW | ROCHESTER | MN | 55905-0001 | OLMSTED | USA | R01HL171056 | INTEGRATION OF MECHANICAL AND MOLECULAR CUES DURING DISTAL LUNG DEVELOPMENT | 001 | 3 | NIH | 3/25/2026 | $17,743 |
|
